Tumour necrosis factor alpha in fat redistribution syndromes associated with combination antiretroviral therapy in HIV-1-infected patients: Potential role in subcutaneous adipocyte apoptosis

Pere Domingo, F. Vidal, J. C. Domingo, S. Veloso, M. A. Sambeat, F. Torres, J. J. Sirvent, J. Vendrell, X. Matias-Guiu, C. Richart

Research output: Contribution to journalArticleResearchpeer-review

36 Citations (Scopus)

Abstract

Background: The pathogenesis of fat redistribution syndromes (FRS) observed in the setting of highly active antiretroviral therapy (HAART) for the treatment of HIV-1-infection remains elusive. A dysregulation of the tumour necrosis factor alpha (TNF-α) system occurs in HIV-infected patients with FRS. Materials and methods: The study looked at both the in vivo and in vitro relationship between TNF-α and the degree of subcutaneous adipocyte apoptosis in 60 HIV-1-infected patients on HAART with FRS, another 60 HIV-1-infected patients on HAART without FRS and 60 uninfected control patients. Apoptosis was assessed by the terminal deoxynucleotidyl transferase dUTP (deoxyuridine 5′-triphosphate)-digoxigenin Nick End Labelling (TUNEL) method. Soluble receptors of TNF-α were determined by the sandwich enzyme immunoassay technique. The in vitro viability was assessed by staining with 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide (MTT) and apoptosis by TUNEL. Results: HIV-1-infected patients with FRS had significantly higher degrees of subcutaneous adipocyte apoptosis than those without FRS (P = 0.0001) and uninfected controls (P < 0.0001). There was a statistically significant association between serum levels of soluble TNF-α receptors #1 and #2 and the degree of subcutaneous adipocyte apoptosis in patients with and without FRS (P < 0.0001 for both receptors). In vitro, the addition of TNF-α (10 ng mL-1) to an adipocyte culture embedded with indinavir, either alone or in clinically relevant combinations with stavudine (d4T) and lamivudine (3TC), significantly decreased adipocyte viability (P = 0.0001) and increased adipocyte apoptosis (P < 0.0001) with respect to that observed with the addition of antiretrovirals alone. Conclusions: TNF-α plays a significant role in subcutaneous adipocyte apoptosis, which occurs in the setting of FRS in HIV-1-infected patients on highly active antiretroviral therapy. © 2005 Blackwell Publishing Ltd.
Original languageEnglish
Pages (from-to)771-780
JournalEuropean Journal of Clinical Investigation
Volume35
DOIs
Publication statusPublished - 1 Jan 2005

Keywords

  • HIV-1 infected
  • Highly active antiretroviral therapy
  • Lipodystrophy
  • Subcutaneous adipocyte apoptosis
  • TNF-α
  • Tnf-α receptors

Fingerprint Dive into the research topics of 'Tumour necrosis factor alpha in fat redistribution syndromes associated with combination antiretroviral therapy in HIV-1-infected patients: Potential role in subcutaneous adipocyte apoptosis'. Together they form a unique fingerprint.

Cite this